Confirm the presence of BRAF V600E mutation in tumor specimens prior to initiation of treatment with Dabrafenib.
The recommended dose for Dabrafenib is 150 mg orally taken twice daily, approximately 12 hours apart, until disease progression or unacceptable toxicity occurs. Take either at least 1 hour before or at least 2 hours after a meal.
A missed dose can be taken up to 6 hours prior to the next dose. Do not open, crush, or break Dabrafenib capsule.
For New Primary Cutaneous Malignancies: No dose modifications are recommended.
from FDA,2013.05
Dabrafenib is a targeted therapy that has demonstrated significant therapeutic potential in clinical applications for specific cancer types. This article will provide an in-depth d···【more】
Article source:Lucius LaosRelease date:2025-01-13Recommended:99
Dabrafenib is an important therapeutic drug, and its dosage has attracted much attention.What is the dosage of dabrafenibKnowing the correct dosage of dabrafenib is essential to en···【more】
Article source:Lucius LaosRelease date:2025-01-13Recommended:132
Dabrafenib is an important anti-cancer drug, and its correct use is crucial to the patient's treatment outcome.How to use the Laos Lucius version of dabrafenibThe use of dabraf···【more】
Article source:Lucius LaosRelease date:2025-01-10Recommended:170
Dabrafenib is a drug used to treat a specific type of cancer, and its correct dosage is essential to ensure that the treatment is effective.What is the recommended dosage of Laos L···【more】
Article source:Lucius LaosRelease date:2025-01-10Recommended:141
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: